Intel (INTC) Sep 2025 Filing Analysis

The filing reaffirmed the end-of-2025 launch timeline but provided no evidence that the first 18A SKU had been released by September 27, 2025. (1 not yet due, 3 in progress, 1 met across 5 tracked commitments)

Release the first SKU manufactured on Intel 18A. — target: First SKU of Intel 18A-manufactured products

Use proceeds from strategic equity placements to support advanced manufacturing, AI infrastructure, and long-term growth initiatives. — target: $2.0 billion SoftBank placement and $5.0 billion NVIDIA placement

The latest quarter showed a sequentially favorable demand signal inside a weaker year-to-date trend: CCG revenue grew 4.6% year over year in Q3, while client average selling prices rose 2%. However, profitability weakened because the product mix shifted toward newer, more expensive products. This is best viewed as a margin contraction despite quarterly revenue expansion. (1 contracting, 3 expanding, 1 stable)

All Other expanded materially year to date, helped by Mobileye and other non-reportable businesses. Revenue grew 20.1%, from $2.488B to $2.989B, and the category moved from an operating loss to operating income. Mobileye revenue rose 25.6% year to date, while Q3 Mobileye revenue increased 3.7%. The category became profitable, although the eventual deconsolidation of 51% of Altera changes its composition. (2 expanding, 2 shifted)

CCG remained Intel's largest operating segment, but its year-to-date revenue share slipped from 63.3% of consolidated revenue to 61.3%. Revenue declined year over year as lower first-half client volumes and customer inventory levels outweighed stronger Q3 demand. The latest quarter itself improved, with Q3 revenue up 4.6% year over year, but operating income fell 8.3% because newer products carried higher unit costs and inventory reserves increased. (2 contracting)

Intel had $30.935 billion of cash and short-term investments against $46.553 billion of debt at Q3 FY25, while Foundry was still losing $7.809 billion year to date. The company also faced Fab 34 construction-delay damages of up to $1.1 billion and future minimum-output obligations under Ireland SCIP. Management reported a BBB credit-rating downgrade and warned that borrowing costs and capital-market access could be affected. By the Jun. 2026 baseline, cash and short-term investments had fallen to $29.727 billion and debt had risen to $50.537 billion after a $14.2 billion Ireland SCIP stake repurchase. The risk therefore intensified from HIGH to HIGH, with materially less financial flexibility. (1 intensifying)